INTRA-CELLULAR THERAPIES INC earnings per share and revenue

23I earnings per share for the last quarter are -0.22 EUR whereas the estimation was -0.16 EUR which accounts for -39.48% surprise. Company revenue for the same period amounts to 157.51 M EUR despite the estimated figure of 154.75 M EUR. Estimated earnings per share for the next quarter are -0.06 EUR, and revenue is expected to reach 187.52 M EUR. Also watch annual changes over time to get a bigger picture of 23I earnings per share and revenue dynamics.